Your browser doesn't support javascript.
loading
Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.
Costas, Laura; Lujan-Barroso, Leila; Benavente, Yolanda; Allen, Naomi E; Amiano, Pilar; Ardanaz, Eva; Besson, Caroline; Boeing, Heiner; Bueno-de-Mesquita, Bas; Cervenka, Iris; Fortner, Renée T; Fournier, Agnès; Gunter, Marc; Harlid, Sophia; Huerta, José María; Jerkeman, Mats; Jirström, Karin; Kaaks, Rudolf; Karakatsani, Anna; Khaw, Kay-Tee; Kotanidou, Anastasia; Lund, Eiliv; Masala, Giovanna; Mattiello, Amalia; Melin, Beatrice; Menéndez, Virginia; Murphy, Neil; Nieters, Alexandra; Overvad, Kim; Riboli, Elio; Sacerdote, Carlotta; Sánchez, Maria-Jose; Schmidt, Julie A; Sieri, Sabina; Tjønneland, Anne; Trichopoulou, Antonia; Tumino, Rosario; Vermeulen, Roel; Weiderpass, Elisabete; de Sanjosé, Silvia; Agudo, Antonio; Casabonne, Delphine.
Afiliação
  • Costas L; Unit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
  • Lujan-Barroso L; Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
  • Benavente Y; Department of Nursing of Public Health, Mental Health and Maternity and Child Health, School of Nursing, Universitat de Barcelona, Barcelona, Spain.
  • Allen NE; Unit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
  • Amiano P; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
  • Ardanaz E; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
  • Besson C; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
  • Boeing H; Public Health Division of Gipuzkoa, BioDonostia Health Research Institute, San Sebastian, Spain.
  • Bueno-de-Mesquita B; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
  • Cervenka I; Navarra Public Health Institute, Pamplona, Spain.
  • Fortner RT; Unit of Hematology-Oncology, Centre Hospitalier de Versailles, Le Chesnay, France.
  • Fournier A; Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
  • Gunter M; Institut Gustave Roussy, Villejuif, France.
  • Harlid S; German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Huerta JM; Department of Determinants of Chronic Diseases, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Jerkeman M; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Jirström K; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St. Mary's Campus, London, United Kingdom.
  • Kaaks R; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Karakatsani A; Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
  • Khaw KT; Institut Gustave Roussy, Villejuif, France.
  • Kotanidou A; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Lund E; Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine-Université Paris-Sud and Faculté de Médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France.
  • Masala G; Institut Gustave Roussy, Villejuif, France.
  • Mattiello A; International Agency for Research on Cancer, Lyon, France.
  • Melin B; Department of Radiation Sciences, Oncology, Faculty of Medicine, Umeå University, Umeå, Sweden.
  • Menéndez V; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
  • Murphy N; Department of Epidemiology, Murcia Regional Health Council, Instituto Murciano de Investigación Biosanitaria-Arrixaca, Murcia, Spain.
  • Nieters A; Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
  • Overvad K; Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
  • Riboli E; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Sacerdote C; Hellenic Health Foundation, Athens, Greece.
  • Sánchez MJ; Department of Pulmonary Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University General Hospital, Haidari, Greece.
  • Schmidt JA; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Sieri S; Hellenic Health Foundation, Athens, Greece.
  • Tjønneland A; Department of Critical Care Medicine and Pulmonary Services, University of Athens Medical School, Evangelismos Hospital, Athens, Greece.
  • Trichopoulou A; Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.
  • Tumino R; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.
  • Vermeulen R; Dipartimento di Medicina Clinica e Chirugia, Federico II University, Naples, Italy.
  • Weiderpass E; Department of Radiation Sciences, Oncology, Faculty of Medicine, Umeå University, Umeå, Sweden.
  • de Sanjosé S; Public Health Directorate, Asturias, Spain.
  • Agudo A; International Agency for Research on Cancer, Lyon, France.
  • Casabonne D; Center for Chronic Immunodeficiency at the Center for Translational Cell Research, University of Freiburg Medical Center, Freiburg, Germany.
Am J Epidemiol ; 188(2): 274-281, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30481275
The role of hormonal factors in the etiology of lymphoid neoplasms remains unclear. Previous studies have yielded conflicting results, have lacked sufficient statistical power to assess many lymphoma subtypes, or have lacked detailed information on relevant exposures. Within the European Prospective Investigation Into Cancer and Nutrition cohort, we analyzed comprehensive data on reproductive factors and exogenous hormone use collected at baseline (1992-2000) among 343,458 women, including data on 1,427 incident cases of B-cell non-Hodgkin lymphoma (NHL) and its major subtypes identified after a mean follow-up period of 14 years (through 2015). We estimated hazard ratios and 95% confidence intervals using multivariable proportional hazards modeling. Overall, we observed no statistically significant associations between parity, age at first birth, breastfeeding, oral contraceptive use, or ever use of postmenopausal hormone therapy and risk of B-cell NHL or its subtypes. Women who had undergone surgical menopause had a 51% higher risk of B-cell NHL (based on 67 cases) than women with natural menopause (hazard ratio = 1.51, 95% confidence interval: 1.17, 1.94). Given that this result may have been due to chance, our results provide little support for the hypothesis that sex hormones play a role in lymphomagenesis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia de Reposição de Estrogênios / Linfoma de Células B / História Reprodutiva Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Am J Epidemiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia de Reposição de Estrogênios / Linfoma de Células B / História Reprodutiva Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Am J Epidemiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha